Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636875012 | Drotaverine hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4636876013 | Drotaverine hydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Drotaverine hydrochloride (substance) | Is a | Smooth muscle relaxant (substance) | true | Inferred relationship | Some | ||
| Drotaverine hydrochloride (substance) | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Drotaverine hydrochloride (substance) | Is a | Isoquinoline (substance) | true | Inferred relationship | Some | ||
| Drotaverine hydrochloride (substance) | Is a | Phosphodiesterase 4 inhibitor | true | Inferred relationship | Some | ||
| Drotaverine hydrochloride (substance) | Has disposition (attribute) | Phosphodiesterase 4 inhibitor (disposition) | true | Inferred relationship | Some | ||
| Drotaverine hydrochloride (substance) | Is modification of (attribute) | Drotaverine (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Drotaverine hydrochloride 20 mg/mL solution for injection | Has precise active ingredient | True | Drotaverine hydrochloride (substance) | Inferred relationship | Some | 1 |
| Drotaverine hydrochloride 20 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Drotaverine hydrochloride (substance) | Inferred relationship | Some | 1 |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Drotaverine hydrochloride (substance) | Inferred relationship | Some | 1 |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Drotaverine hydrochloride (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR